|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2018||2019||2020||2021||2022||2023E||2024E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
KP Tissue Inc. is a Canada-based company, which was created to acquire, and its business is limited to holding, an equity interest in Kruger Products Inc. (Kruger Products). Kruger Products’ principal business is to produce, distribute, market and sell a range of disposable tissue products, including bathroom tissue, facial tissue, paper towels and napkins for both the consumer and away-from-home markets in North America. The Company operates through two segments: Consumer and Away-From-Home (AFH). The Consumer segment consists of brands, such as Cashmere, Purex, Scotties, SpongeTowels and Bonterra in Canada and White Cloud in the United States. AFH segment offers bathroom tissue, facial tissue, paper towels, paper napkins, wipers, hand care, and dispensing systems for use in the food service, property management, healthcare, manufacturing, education, and lodging segments across North America.
As of Today at 18:13 UTC, shares in KP Tissue are trading at CA$9.48. This share price information is delayed by 15 minutes.
Shares in KP Tissue last closed at CA$9.48 and the price had moved by -6.88% over the past 365 days. In terms of relative price strength the KP Tissue share price has underperformed the Toronto Stock Exchange 300 Composite Index by -5.58% over the past year.
The overall consensus recommendation for KP Tissue is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The KP Tissue dividend yield is 7.59% based on the trailing twelve month period.
Last year, KP Tissue paid a total dividend of CA$0.72, and it currently has a trailing dividend yield of 7.59%.Looking ahead, shares in KP Tissue are due to go ex-dividend on 2023-12-29 and the next dividend pay date is 2024-01-15.
KP Tissue are due to go ex-dividend on 2023-12-29 and the next dividend pay date is 2024-01-15. The historic dividend yield on KP Tissue shares is currently 7.59%.
To buy shares in KP Tissue you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$9.48, shares in KP Tissue had a market capitalisation of CA$94.46m.
Here are the trading details for KP Tissue:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: KPT
Based on an overall assessment of its quality, value and momentum KP Tissue is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in KP Tissue is CA$10.88. That is 14.77% above the last closing price of CA$9.48.
Analysts covering KP Tissue currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.10 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like KP Tissue. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -8.67%.
As of the last closing price of CA$9.48, shares in KP Tissue were trading -6.62% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The KP Tissue PE ratio based on its reported earnings over the past 12 months is 23.68. The shares last closed at CA$9.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
KP Tissue's management team is headed by:
- Francois Vimard - NEC
- Dino Bianco - CEO
- Mark Holbrook - CFO
- Gordon Goss - SVP
- Michel Manseau - SVP
- Susan Irving - CMO
- Francois Paroyan - GCN
- Louise Wendling - DRC
- James Hardy - IND
- Michel Letellier - IND